Access Infinity
Leading Digital Transformation in Market Access

There’s a corner of the pharmaceutical industry that few talk about and even fewer understand. It’s a vital part of bringing a new drug to market. Activities carried out by market access teams are critical in determining a drug’s price and level of access patients have. Despite its importance, the way many market access teams gather insights could be said to be stuck in the stone age. As other areas of the industry enthusiastically embrace the advantages of digital tools and technology, market access seems to have stayed in the past.

Transformative cloud-based platforms

However, there are some innovative companies out there trying to bring powerful digital solutions to the market access space. One of the biggest names is Access Infinity, a firm headquartered in London with offices in the US and India, that is changing how market access teams’ work. Founded in 2014, the company originally began as an advisory services firm to guide pharma businesses in developing and implementing effective market access and pricing strategies. But when founders, Dr Shrinivas Rao Mukku and Ahmed Edathodu, recognised the need for insights to drive better pricing and access decisions, they began developing cloud-based solutions to fill the gap. One of the first solutions that Access Infinity developed was: Access Hub.

Access Hub

Several pharma companies still use manual Excel spreadsheets to track access milestones. Often these teams do not even measure access KPIs or track critical metrics which consequently leads to loss of institutional knowledge about past launches and with that, any learnings that could be brought forward to optimise ongoing and future launches. By not measuring KPIs, market access teams are also unable to quantify how they’re adding value to the brand team.

Access Hub helps users track market access KPIs and launch activities across global markets. It streamlines the entire process for senior management by creating a single source of truth for tracking reimbursement metrics across multiple products, indications, and regions. “It’s our flagship product. It has transformed how market access teams working pharma and brought muchneeded sophistication to the function, enabling decision-makers to find the information they need at their fingertips,” says Ahmed.

“What you get with Access Hub is over 7 years of expertise in defining, tracking and reporting of access KPIs as well as the collective launch tracking experience of over 50drugs.” Over the years, Access Hub has risen through the ranks in the pharma industry, winning clients such as Pfizer, Astellas, Gilead, Intercept, and more. Today, following the resounding success of Access Hub, Access Infinity has added two further digital products to its portfolio: Evidence Hub and Nuro.

Evidence Hub is a cloud-based platform that enables smarter, more efficient, and transparent decisionmaking and strategy development with its state-of-the-art market access and Health Economics and Outcomes Research (HEOR) functionalities. Evidence Hub facilitates medical/ HEOR teams to store, analyse, identify and easily manage evidence generation projects and publications of interest. “Evidence Hub is a tailor-made productivity platform for HEOR teams to effectively collaborate and work from a single repository that allows finding information and creating reports a piece of cake,” says Nagaraja.

Access Infinity’s digital tools have become the gold-standard for the industry and are helping our clients make better and faster decisions

Nuro is a comprehensive data platform that combines HTA insights, clinical evidence, pricing intelligence, among other critical business insights under a single pane of glass. Nuro allows users to apply numerous matching criteria and identify relevant product analogues, which gives them an understanding of better-suited pricing and launch strategies. This coupled with over 450 data points for every single approved product across all major markets, competitive benchmarking has never been easier.

Apart from its tools, Access Infinity also boasts comprehensive consulting services that combine the company’s team expertise with the data gathered by Nuro to deliver powerful market insights.

Best-in-class Market Access Tools and Knowledge

Discussing the core competencies of Access Infinity’s portfolio, Nagaraja elaborates, “We have struck the perfect balance of offering technologies that holistically enhance the efficiencies of market access functions and backing it up with strong consulting expertise.” He further mentions how the company’s solutions are not just typical IT offerings but carefully designed and tailor-made by and for pharma market access and pricing functions, which is a key attribute in Access Infinity’s long-running success.

The company also places a strong emphasis on developing strong customer relationships through its commitment to continually deliver real value by developing deeper market access-related capabilities.

Another key facet that plays a vital role in the company’s track record of client excellence is its team of dedicated, passionate, and highly competent professionals from the realms of technology, pharmaceuticals, product development, and healthcare, among others. “Our tools and services are built to make a difference, but it is our people that make it a reality for our customers. We have a strong culture that challenges all of us to deliver the very best-in-class solutions to our clients” observes Mukku.
Expanding into More Countries

Access Infinity plans to expand its footprint in more countries, particularly in India and the U.S. where the company has already opened offices and is in the process of scaling the workforce. In fact, Mukku adds how his company’s strong brand and reputation facilitates the recruitment of top senior executives, a prime example of this being the recruitment of seasoned digital leader, Keshav Nagaraja, who is poised to bring in his expertise to enhance Access Hub, Evidence Hub and Nuro’s capabilities.

With these developments, Access Infinity wants to maintain its annual growth rate of 40% and grow that number in the coming years. From a technology standpoint, the company is developing AI/ML-based tools that will simplify a client’s decision-making and strategy development while adding more value. Moreover, the company’s roadmap is geared toward the creation of more innovative digital solutions and improved customer service.

With its unique blend of expertbacked consulting services and innovative technology tools, Access Infinity is on a mission to help pharma businesses across the globe gain actionable insights that will help price their products better and ensure patients have access to the medicines they need.